CoSign Digital Signatures for Life Sciences

With the number of new blockbuster drugs discovered decreasing, sponsors are under pressure to find efficiencies in the drug development process. To speed up processes and cut costs, sponsors are increasingly forming collaborative networks where CSO's play a major role.

Digital signatures enhance CSO's by allowing compliant digital signatures to be placed from within the software and removing the need to resort to paper and absorb paper-based delays for:

• Increase security and control for audits
• Cut routing costs and ensure timely reporting
• Ensure integrity of reports